Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc. financial statements

Senti Biosciences Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 22K10-K
Net income−USD 61.44M10-K
Cash and equivalentsUSD 16.42M10-Q
Total debtUSD 28.89MEODHD

Senti Biosciences Holdings, Inc. financials on 6ix · Senti Biosciences Holdings, Inc. on 6ix